Raise $100K for Our Next Clinical Trial
MRF Principal Investigator Steve Miller, Professor of Biomedical Sciences from Northwestern University, has a promising idea for an MS treatment
In multiple sclerosis, the immune system sees myelin proteins as foreign material and attacks them. Recent research indicates that we may be able to "trick" the immune system into believing that the myelin protein is not a foreign material.
Bringing this idea to a clinical trial will help us determine whether this innovative treatment is safe and effective for MS patients.
MRF needs your help to make this clinical trial a reality.
The total cost is over $2 million. However, through collaborations with other funders, the MRF is providing only $200,000 for the trial over the next two years. ($100,000 for the first year and $100,000 for the second year).
Donate today. Help us reach the goal of $100,000 by June 30.
Remember, your contributions to the clinical trial will be matched 100% thanks to another generous donor -- doubling your impact and bringing us straight to the finish line.
Share the news about the potential of this clinical trial to 10 friends and family and help us spread the word.
Thank you for your continued interest and support.
Scott Johnson
President
Myelin Repair Foundation
18809 Cox Avenue, Suite 190
Saratoga, CA 95070
www.myelinrepair.org
Notes: This is an early stage clinical trial being conducted in one research institution. All clinical trials patients have already been selected.
If for some reason the clinical trial does not move forward as planned, you can be assured that 100% of your donation will be used to support other myelin repair research conducted by the MRF.
No comments:
Post a Comment